Johnson & Johnson Continues Gains for Eight Straight Sessions
J&J Reportedly Seeking Additional Support for Talc Bankruptcy Plan
$100 Invested In This Stock 5 Years Ago Would Be Worth $500 Today
Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets
U.S. to Restart Free COVID Test Program as Cases Spike
Merck, Bristol Myers Cancer Drugs Included in September FDA Advisory Panel Meeting
Deep Sea : No bad news. Need to wait for funds to push up.